AMED NASDAQ
Amedisys, Inc.
1W: +0.1%
1M: +3.6%
3M: +7.8%
1Y: +3.0%
3Y: -17.4%
5Y: -56.5%
$100.99
Last traded 2025-08-15 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$2B
Revenue
+4.9% YoY
$150M
Net Income
+33.6% YoY
$235M
Free Cash Flow
+165.7% YoY
79.0%
Gross Margin
7.3%
Op. Margin
10.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE12.7%
ROA6.9%
ROIC5.3%
Valuation
P/E76.5
P/B2.9
EV/EBITDA20.3
Leverage
Debt/Equity0.37
Current Ratio1.36
Interest Cov.6.0x
Quality Scores
Piotroski F9/9
Altman Z4.04
Beneish M-3.03